ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2026

A Phase 3, Randomized Trial Investigating the Safety, Tolerability, and Immunogenicity of V116, an Adult-Specific Pneumococcal Conjugate Vaccine, in Pneumococcal Vaccine-Naïve Adults 18-64 Years of Age at Increased Risk of Pneumococcal Disease, STRIDE-8.

Paul T Scott et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.